Your Partner for Leading Kidney Research

From chronic kidney disease (CKD) to rare glomerular disorders, our renal CRO services provide agile, patient‑centric solutions that fuel recruitment, prioritize safety, and deliver change for patients worldwide.

63k+
renal study patients recruited
80+
renal clinical trials completed
70+
global geographies supported
79%
of staff have nephrology expertise

Setting the Standard for Renal Trials

The global renal burden is real, and addressing it is central to our mission.

By conducting studies in diverse locations, we consider genetic variations and underserved populations, broadening real‑world results and expanding access to advanced treatments.

Through our extensive global site alliances and on‑the‑ground renal CRO specialists, we connect you to diverse patient populations with varied indications worldwide, including in the rapidly emerging APAC region.

Our vast renal expertise encompasses deep knowledge in CKD, IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), and acute kidney injury, among other conditions.

We also support pharmacogenomics studies, helping to identify targeted therapies and advance precision medicine.

From studies in all phases to post‑marketing surveillance, our global experts deliver excellence at every step.

Renowned for our renal scientific leadership, we excel in innovating and executing complex trials that yield robust evidence, driving real change in treatments, clinical practice, and policy.

By integrating scientific expertise with operational excellence, we optimize trial efficiency and data integrity, advancing renal research and patient care.

Strategic Leadership in Action

Courtney Cordaro

Courtney Cordaro MBA, PMP​​​​

Therapeutic Strategy Director

As Therapeutic Strategy Director, Courtney develops region‑specific trial strategies that meet regulatory requirements and ensure successful delivery. She brings over 12 years of renal clinical research experience across sponsor and CRO companies, including Shire (now Takeda) and Frenova Renal Research.

Courtney has worked on programs spanning multiple indications in CKD and end‑stage renal disease (ESRD), including several that led to full FDA approval. She works closely with sponsors to design patient‑centric protocols that fit into patients’ busy lives while meeting primary endpoints.

Committed to staying ahead of the curve, Courtney’s deep understanding of the landscape drives innovative trial strategies that advance renal care.

From Planning to Patients, We Deliver

Partnering with us means faster start‑up, recruitment of the most suitable patients, and efficient execution from trial design to clinical conclusions.

Our robust, data‑oriented approach includes advisory board selection, protocol design, and site selection. With meticulous attention to detail, we deliver compliant, tailored renal trials that meet your goals.

Through centralized data management, statistical analysis, and pharmacovigilance experience, we deliver impactful results while striking the critical balance between benefit and risk to protect patient outcomes and trial integrity.

Driven by a commitment to improving lives, our responsive cross‑functional teams bring regional expertise, cultural sensitivity, and a streamlined approach to multi‑country trials that gets your innovations to patients sooner.

Our areas of expertiseMeet our team

Custom Solutions for Renal Research

With flexible, comprehensive capabilities tailored to renal trials, you can choose the help you need, from individual services to end‑to‑end solutions.

Patient Recruitment

Accelerate recruitment through our global alliances with trusted sites, including a strong APAC presence.

Study Design & Start‑Up

Develop custom, cost‑effective programs and protocols for projects of any complexity.

Data Management & Biostatistics

Get accurate, secure, and integrated solutions to maximize impact from start to finish.

Safety & Pharmacovigilance

Ensure patient safety with comprehensive risk management and surveillance strategies.

Frequently asked questions

What types of renal trials can you support?

We support renal clinical trials across every phase, from first‑in‑human studies to post‑marketing pharmacovigilance. With an industry‑leading global network of therapeutic experts and coveted site relationships, we deliver excellence across a broad range of kidney diseases. Request a proposal to find out how we can help you.

Can you support multi‑national or global renal trials?

Absolutely. We have on‑the‑ground teams in 40+ locations worldwide, including in the emerging APAC region. Our expansive network of global key opinion leaders (KOLs) and established site relationships yield exceptional recruitment and retention rates across diverse patient populations. Local experts ensure cultural sensitivity, streamlined communication, and a deep understanding of clinical practices across all renal CRO services.

What steps do you take to ensure compliance with evolving regulations?

We monitor regulatory changes globally and adapt strategies to maintain compliance. Our dedicated team stays updated on evolving standards, liaises with local authorities, and proactively adjusts documentation, processes, and timelines so you can be confident that your trial aligns with the latest requirements in every region. Visit Regulatory Consulting for more information.

What other therapeutic areas do you support?

We bring deep expertise across a wide range of therapeutic areas, from neurology and respiratory diseases to endocrinology and medical devices, with specialized leadership in renal, cardiometabolic, and oncology trials. We’re your partner in advancing impactful therapies that transform lives worldwide, delivering innovative, patient‑centric solutions. Visit Therapeutic Expertise for more information.

Renal Impact & Insights

Take a look at recent renal research breakthroughs and case studies that show how our tailored nephrology CRO services are making a real difference in advancing kidney care.

Driving Success in an Atypical Study

Discover how our world‑leading renal scientific leadership drove engagement and recruitment for a complex Phase I study.

End‑to‑End Services Support FDA Approval

See how we provided a full service for a Phase II multicenter IgAN study that resulted in full FDA approval.

Exceptional Delivery of a Landmark Study

Read how our deep experience and cultural understanding enabled rapid recruitment and eliminated communication gaps.

Exceeding Recruitment Targets in IgAN

See how our scientific leadership model drove optimum recruitment for this milestone rare disease trial.